Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today

Tesla Motors Inc (NASDAQ:TSLA) is in the spotlight after Ben Kallo, analyst at Baird, wrote that he expects Elon Musk’s company to report 21,000 deliveries for the third quarter around early next week. That number includes 9,000 Model X deliveries and 12,000 Model S deliveries. Although any number above 20,000 could be positive, negative sentiment could rear its head again shortly after the announcement due to the company’s impending potential merger with SolarCity. Baird has a $338 price target and an ‘Outperform’ rating on the stock. A total of 36 investors tracked by us owned shares of Tesla Motors Inc (NASDAQ:TSLA) at the end of June, down by three funds from the previous quarter.

Follow Tesla Inc. (NASDAQ:TSLA)
Trade (NASDAQ:TSLA) Now!

Pfizer Inc. (NYSE:PFE) has officially closed its purchase of Medivation, which it agreed to buy for $81.5 in cash per share, for a total enterprise value of $14 billion. Medivation has a leading position in oncology, and Pfizer’s management continues to expect the purchase to be $0.05 accretive to adjusted EPS in the first full year and for additional growth and accretion after that. The number of funds from our database with holdings in Pfizer Inc. (NYSE:PFE) fell by 25 quarter-over-quarter to 94 at the end of June.

Follow Pfizer Inc (NYSE:PFE)
Trade (NYSE:PFE) Now!


DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.